Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Recent trends in the medical treatment of Hodgkin's disease.

× No keyword cloud information.

8 in total

Review 1. [Hodgkin's disease. Results in diagnosis and treatment (author's transl)].

Authors: D Huhn; W Wilmanns
Journal: Klin Wochenschr Date: 1979-04-17

2. Prolonged disease-free survival in MOPP-resistant Hodgkin's disease after treatment with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD).

Authors: A Santoro; G Bonadonna
Journal: Cancer Chemother Pharmacol Date: 1979 Impact factor: 3.333

3. [A modified MOPP regimen in the treatment of Hodgkin's disease stage III B and IV (author's transl)].

Authors: F J Tigges; E Hiller; R M Schmülling; H D Waller; K Wilms
Journal: Blut Date: 1978-08-15

4. [Stage IIIB and IVB Hodgkin's disease. Response to chemotherapy, relapses, survival rates (author's transl)].

Authors: R Kuse; A Calavrezos; A Hinrichs; K Hausmann
Journal: Klin Wochenschr Date: 1981-07-01

5. Pharmacokinetics of dacarbazine (DTIC) and its metabolite 5-aminoimidazole-4-carboxamide (AIC) following different dose schedules.

Authors: H Breithaupt; A Dammann; K Aigner
Journal: Cancer Chemother Pharmacol Date: 1982 Impact factor: 3.333

6. Adriamycin, bleomycin, vinblastine and imidazole carboxamide (ABVD) therapy for advanced Hodgkin's disease resistant to mustine, vinblastine, procarbazine and prednisolone (MVPP).

Authors: S B Sutcliffe; P F Wrigley; A G Stansfeld; J S Malpas
Journal: Cancer Chemother Pharmacol Date: 1979 Impact factor: 3.333

7. Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496).

Authors: Leo I Gordon; Fangxin Hong; Richard I Fisher; Nancy L Bartlett; Joseph M Connors; Randy D Gascoyne; Henry Wagner; Patrick J Stiff; Bruce D Cheson; Mary Gospodarowicz; Ranjana Advani; Brad S Kahl; Jonathan W Friedberg; Kristie A Blum; Thomas M Habermann; Joseph M Tuscano; Richard T Hoppe; Sandra J Horning
Journal: J Clin Oncol Date: 2012-11-26 Impact factor: 44.544

8. [Results of treatment with ABVD in C-MOPP-resistant Hodgkin's disease (author's transl)].

Authors: W Gassmann; L Perenyi; H Pralle; M Graubner; N Schmitz; H Löffler
Journal: Klin Wochenschr Date: 1981-03-16

8 in total